Google Research Unveils Cuff-Free Blood Pressure Monitoring for Smartwatches
For years, the potential of smartwatches to monitor blood pressure sans a cuff has been a tantalizing promise, yet many have found it necessary to rely on traditional calibration methods.
Recent breakthroughs by Google Research herald a promising advance, showcasing an artificial intelligence model that taps into existing smartwatch sensors to identify signs of hypertension without the need for a cuff.
This innovative approach diverges significantly from conventional expectations. Rather than offering specific systolic or diastolic values, the system examines data accumulated over several days from the watch’s optical pulse sensor and accelerometer.
These sensors are adept at detecting both physical movement and the minute vibrations triggered by each heartbeat.
By incorporating the wearer’s height, the model generates a probability score indicating the likelihood of chronic high blood pressure. This research, spearheaded by Paolo Di Achille and Ming-Zher Poh, is documented in the journal Nature.
This distinction is vital. Existing cuffless alternatives, like Samsung’s Galaxy Watch blood pressure monitoring feature, still necessitate regular calibration against a conventional cuff, essentially basing their readings on established benchmarks.
In contrast, Google’s model was developed without relying on medical labels, utilizing an extensive dataset of over 492,000 hours derived from sensory inputs across 2,109 participants.
While clinical outcomes present a compelling narrative, they remain far from definitive. An examination involving 196 individuals at five sites across the United States revealed that the smartwatch detected 65.8% of hypertension cases, surpassing the 55.3% accuracy of a solitary reading taken during a physician visit.
Moreover, it accurately excluded the condition in 90% of individuals without hypertension. In a smaller follow-up involving 48 individuals with initially elevated readings, the watch surpassed the results of repeat clinical visits, although comprehensive home cuff monitoring still identified a broader array of cases.
However, the constraints of this study are pronounced. As an initial screening tool, the smartwatch overlooked nearly one-third of those with hypertension.
All participants were located in the United States, had no prior history of heart disease, and were not on blood pressure medication, raising questions about the applicability of these findings to a wider demographic.
Google has yet to disclose which specific smartwatch models will be compatible with this new monitoring capability or whether it has achieved regulatory endorsement.
Google has indicated that this research has influenced the development of a blood pressure trends feature within its Google Health app.
The project is positioned as a proactive encouragement for users to seek medical evaluation, rather than serving as a definitive diagnosis.
This advancement positions Google in competition with Apple, which has already introduced hypertension notifications on Apple Watch in various markets, including the UAE and Saudi Arabia.
Considering Google’s estimation that over half of the world’s billion-plus individuals with hypertension remain unaware of their condition, even a less-than-perfect early detection system holds considerable merit.
The pressing question remains whether users will interpret a missed alert as a reassuring confirmation of good health.
Source link: Absolutegeeks.com.
